Hepatera
Webболее 550 пациентов в клинических исследованиях. Bogomolov P. et al. J Hepatol, 2016, 65: 490-8. Wedemeyer H. et. al. J Hepatol ... Web22 dic 2015 · PEG-INF-a is used for the treatment of chronic hepatitis delta. The study endpoints are virological response (HBsAg, hepatitis delta virus ribonucleic acid (HDV …
Hepatera
Did you know?
An entry inhibitor that is being developed by MYR GmbH for the treatment of chronic HDV and HBV infections. Received its first approval on 31 July 2024 in the EU. Approved for use in chronic HDV infection in HDV RNA positive adult patients with compensated liver disease. WebUno studio multicentrico, in aperto, randomizzato, comparativo, a bracci paralleli, di fase II per valutare l'efficacia e la sicurezza di Myrcludex B in combinazione con peginterferone alfa-2a contro peginterferone alfa-2a da solo in pazienti con …
Web25 mag 2016 · Hepatera is a biotechnology company. The main activity of the company is development of safe and effective drugs for the treatment of liver diseases for the … Web12 dic 2012 · MOSCOW--(BUSINESS WIRE)--Hepatera, a Russian biotech company and part of Maxwell Biotech Venture Fund’s portfolio, has announced today the inclusion of the first three patients with chronic ...
WebHepatera General Information. Description. Operator of a biotechnology company intended for the prevention and treatment of liver diseases. The company's … WebHEPA (/ ˈ h ɛ p ə /, high-efficiency particulate air) filter, also known as high-efficiency particulate absorbing filter and high-efficiency particulate arrestance filter, is an efficiency …
Web28 nov 2024 · Hepatera LLC is a private biotech company. The main activity of the company is the development of safe and effective drugs for the treatment of liver diseases for the …
Web6 mar 2014 · Hepatera was founded in 2011 with the goal of developing and launching innovative therapeutics for treatment of liver diseases into the Russian market. chestnut and horse chestnutWebLead Sponsor: Hepatera Ltd. Fonte: Hepatera Ltd. Breve riassunto: Sottostudio randomizzato in aperto di Myrcludex B (MXB) giornaliero più interferone alfa-2a pegilato (PEG-INF-a) in pazienti con virus dell'epatite B cronica negativo all'antigene e (HBeAg) dell'epatite B (HBV) coinfettato con il virus dell'epatite delta (HDV). goodreads reviews of great circleWeb1 nov 2024 · Hepatera LLC , Moscow, Russia Business: Infectious Date completed: 3/20/12 Type: Venture financing Raised: Not disclosed Investors: Maxwell Biotech Venture Fund; … chestnut and mushroom nut roastWeb6 mar 2014 · A group of 48 patients infected with the hepatitis B virus (HBV) have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd. Hepatera is financed by ... goodreads romance hero hates heroineWebFind company research, competitor information, contact details & financial data for HEPATERA LLC of Moscow, Moscow. Get the latest business insights from Dun & Bradstreet. chestnut and mushroom quicheWeb29 gen 2024 · "Hepatera", Ltd is a private biotechnology company, founded in 2011 with the goal to develop and launch into the Russian market innovative products for … chestnut and mushroom pastaWeb28 nov 2024 · About Hepatera . Hepatera LLC is a private biotech company. The main activity of the company is the development of safe and effective drugs for the treatment of liver diseases for the Russian market. chestnut and mushroom pie recipe